Mustroph, Julian
Lücht, Charlotte M.
Wagemann, Olivia
Sowa, Thomas
Hammer, Karin P.
Sag, Can M.
Tarnowski, Daniel
Holzamer, Andreas
Pabel, Steffen
Beuthner, Bo Eric
Sossalla, Samuel
Maier, Lars S.
Wagner, Stefan
Article History
First Online: 29 January 2019
Duality of interest
: LSM receives compensation for talks for Boehringer Ingelheim, the company that sells empagliflozin. The other authors declare that they have no duality of interest associated with this manuscript.